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The mucin-type carbohydrate Tn cryptantigen (GalNAcal-
O-Ser/Thr, where GalNAc is ?V-acetyl-D-galactosamine) is
expressed in many carcinomas, in haemopoietic disorders
including the Tn syndrome, and on human immunodefi-
ciency virus (HTV) coat glycoproteins, but is not expressed
on normal, differentiated cells because of the expression
of a Tn-processing galactosyltransferase. Using Jurkat T
leukaemic cells which express high levels of Tn antigen due
to deficient Tn galactosylation, we have established the Tn
antigen-mediated gene transfer and demonstrate the con-
siderable efficiency of this approach. We used poly(L-lysine)
conjugates of the monoclonal antibody 1E3 directed against
the Tn antigen to deliver the luciferase and /3-galactosidase
reporter genes to Jurkat cells by receptor-mediated endo-
cytosis. Addition of unconjugated 1E3 reduced transfection
efficiency in a concentration-dependent manner and incu-
bation with free GalNAc abolished DNA transfer completely,
indicating that gene delivery is indeed mediated by the Tn
antigen. Pre-treatment of Jurkat cells with Vibrio cholerae
sialidase, which uncovers additional Tn antigens, resulted in
an improvement of gene transfection. Both human and
chicken adenovirus particles attached to the DNA/polylysine
complex strongly augmented transgene expression. When
the /3-galactosidase (lacZ) gene was delivered to Jurkat cells
by Tn-mediated endocytosis, up to 60% of the cells were
positive in the cytochemical stain using 5-bromo-4-chloro-3-
indolyl-/3-D-galactopyranoside (X-gal) as a chromogenic sub-
strate. The efficiency of the transferrin receptor-mediated
DNA uptake into Jurkat cells was comparatively low,
although these cells were shown to express considerable
amounts of transferrin receptor. We show here that a
mucin-type carbohydrate antigen mediates highly efficient
DNA uptake by endocytosis into Jurkat T cells. This method
represents a 50-fold improvement of Jurkat cell transfection
efficiency over other physical gene transfer techniques.
Specific gene delivery to primary cancer cells exhibiting Tn
epitopes may especially be desirable in immunotherapy
protocols.
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Introduction
The success of gene therapy depends on efficient methods to
deliver genes to somatic cells, including T lymphocytes (Miller,
1992). In addition to retroviral systems which are used in
approved clinical trials (Rosenberg et al., 1990), alternative
physical methods have been elaborated and shown to be
efficient. In a very promising approach designated as trans-
ferrinfection, DNA is bound by a poly-L-lysine (pL) transferrin
(Tf) conjugate and delivered to the cell interior by transferrin
receptor (TfR)-mediated endocytosis (Cotten et al., 1990,
1992; Wagner et al, 1990, 1991a,b, 1992). However, while
the TfR-mediated gene transfer proved to be highly efficient for
many cell types, and in particular for erythroid K562 cells,
T lymphoid cells including Jurkat appeared to be refractory
(Cotten et al., 1993a), calling for different strategies. In earlier
experiments, glycoproteins were used to target DNA to the
lectin-like asialoglycoprotein receptor expressed on hepatocytes
(Wilson et al., 1992). Conversely, it should be possible to use
carbohydrate-specific reagents to target DNA to cells exhibit-
ing these carbohydrate epitopes. An obvious advantage of cell
surface carbohydrates, in particular of the mucin type, as
receptors for gene transfer experiments is their clustered ex-
pression, resulting in high surface densities (Carraway and
Hull, 1991). In fact, a protein-specific monoclonal antibody
(mAb) recognizes a single epitope on a cell surface glyco-
protein, whereas an anti-carbohydrate mAb may bind to
multiple receptors attached to the same protein. Thus, we
decided to target a mucin-type carbohydrate antigen to transfect
Jurkat T cells.
For unknown reasons, Jurkat cells lack O-glycan-specific
j31,3 galactosyltransferase (Gal-T) activity and therefore ex-
press the Tn cryptantigen. The Tn antigen is the initial
carbohydrate structure formed in the biosynthesis of O-linked
carbohydrates of the mucin type, also referred to as O-glycans
(Schachter and Brockhausen, 1989). In normal differentiated
cells, the Tn antigen is cryptic due to carbohydrate chain
elongation or branching. Loss of j31,3Gal-T, the Tn-processing
enzyme, leads to exposure of the Tn antigen which may be
partially sialylated to form the sialosyl-Tn antigen (NeuAca2-
6GalNAcal-O-Ser/Thr, where GalNAc is /V-acetyl-D-galacto-
samine) (Kjeldsen etal., 1989; Blumenfeld et al., 1992).
Deficiency of/31,3Gal-T resulting in Tn/sialosyl-Tn expression
is known to be associated with oncogenic transformation
(Springer, 1984; Singhal and Hakomori, 1990). Expression of
these antigens is particularly well established in breast and
colon cancer (Itzkowitz et al., 1989; Springer, 1989), but also
occurs in the context of haemoproliferative disorders (Roxby
etal., 1992), including acute lymphoblastic T-cell leukaemia
(Piller et al., 1990). Moreover, Tn/sialosyl-Tn expression was
also found in idiopathic Tn syndrome (Thurnher et al., 1992,
1993a), a condition considered to be a pre-leukaemic state.
Finally, the Tn epitope has also been detected on gpl60 and
gpl20 of human immunodeficiency virus (HIV) (Hansen et al.,
1991). mAb against the Tn antigen neutralized infection with
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cell-free virus and blocked syncytium formation. In contrast,
normal adult cells lack detectable Tn antigen expression. Thus,
the Tn antigen is a useful histological marker which delineates
malignant tissue, suggesting that Tn-specific mAb or lectins
(Thurnher et al., 1993b) may have therapeutic potential.
To test Tn antigens as receptors for gene delivery, we have
used polylysine conjugates of the anti-Tn mAb 1E3 to transfect
the luciferase or the /3-galactosidase marker gene to Tn+ Jurkat
T cells which were previously shown to bind 1E3 (Thurnher
et al., 1992). Specific and efficient Tn-mediated gene transfer
to Jurkat T cells could be performed.
Results
The Tn antigen is expressed on Jurkat cells at high density
In a preliminary analysis, we compared the levels of surface
expression of the TfR, the target of the transferrinfection
(Wagner et al., 1992), and of the Tn antigen. The flow cyto-
metric analysis depicted in Figure 1 revealed that the surface
density of the Tn antigen was much higher than that of the TfR
on Jurkat cells (Figure 1, compare B with C, see also Table I).
However, the level of TfR density on Jurkat cells was
surprisingly high when compared to erythroid K562 cells
(Figure 1A and B). In K562 cells, TfR expression can be
upregulated by treatment with desferrioxamine (Mattia et al.,
1984) (see also Figure 1A and Table I). In addition, Jurkat cells
were also stained for the CD43 antigen which is a major Tn
antigen-bearing surface protein on Jurkat cells (Piller et al.,
1990). Figure ID confirms the expression of CD43 on Jurkat
T cells. The CD43 mAb DF-T1 used for this labelling is, like
most of the mAbs recognizing CD43, sialic acid dependent
(Borche et al., 1987). Thus, pre-treatment with Vibrio cholerae
sialidase (VCN) abolished DF-T1 binding (Figure ID, left
peak).
mAb 1E3 mediates gene transfer to Jurkat cells
Previous studies on the receptor-mediated DNA transfer
revealed that one function of the polylysine is the condensation
of the DNA to be transfected into small toroid structures small
enough to be engulfed into coated pits (Wagner et al., 1991b).
Thus, in preliminary experiments the optimal ratio of lE3pL
and pCLuc had to be determined. For this purpose, decreasing
amounts of conjugate were mixed with a constant amount of
DNA and transfected into Jurkat cells in the presence of 100
^M chloroquine. Figure 2 demonstrates that 5 ng of lE3pL and
6 fig of pCLuc resulted in the highest transfection efficiency
(compare 1-5). Therefore, in all further experiments a 5:6 ratio
of conjugate to DNA was used. Despite considerable TfR
expression (Figure IB), transferrinfection of Jurkat cells was 40
times less efficient than Tn-mediated gene delivery (Figure 2,
no. 6). In the absence of chloroquine, transgene expression was
completely prevented (Figure 2, no. 7).
The gene transfer is specifically mediated by the Tn antigen
Flow cytogram C in Figure 1 demonstrated that binding of 1E3
to Jurkat cells was significantly enhanced by enzymatic de-
sialylation with VCN, suggesting that additional Tn epitopes
are unmasked. We have therefore tested the influence of VCN
pre-treatment of Jurkat cells on the Tn-mediated gene transfer.
Figure 3 shows a 19.5% increase in luciferase activity induced
by VCN (compare 1 and 2). However, while the fluorescence
intensity doubled after VCN in the flow cytometric analysis, the
improvement of transfection efficiency was relatively weak.
This may be due to the removal of negative charge carried by
sialic acid which may otherwise bind electrostatically the
polycation lE3pL. Therefore, VCN treatment certainly exposes
additional Tn antigens, as shown in the FACS analysis
presented in Figure 1, but also reduces the electrostatic capacity
of the cell to bind lEpL. Thus, the net effect of enzymatic
desialylation is only a 19.5% increase in transgene expression.
The specificity of the DNA transfer was further assessed by
incubation with either unconjugated 1E3 or in the presence of
free GalNAc. Prior addition of 50 or 100 /tg of unconjugated
1E3, which represents a 12.5- and 25-fold excess of mAb,
respectively, to the transfection medium (2.5 ml) resulted in
a 10 and 33% reduction of luciferase activity (Figure 3, nos 3
and 4). This relatively weak inhibition may be explained by a
clearing of the unconjugated 1E3 from the medium by endo-
cytosis during the 4 h transfection process, followed by binding
and internalization of DNA-loaded lE3pL. However, when the
transfection was set up in the presence of free GalNAc at
30 mM, 1E3 binding and thus DNA uptake was almost
completely absent (Figure 3). These data indicated that the gene
transfer was indeed mediated by the Tn antigen.
Adenovirus augments Tn-mediated gene transfer to
Jurkat cells
The endosome-disrupting activity of viruses which gain entry
to the cell via the endocytotic pathway has been described
previously (Blumenthal et al., 1986; Otero and Carrasco, 1987;
Christiano et al., 1993). The use of either free adenovirus
particles or adenovirus particles included in DNA/pL com-
plexes has been shown to increase transgene expression signi-
ficantly by improving survival of the DNA during intracellular
transport. We have therefore investigated whether adenovirus
particles also augment Tn-mediated gene delivery to Jurkat
cells. For this purpose, we used either human adenovirus
H5d/1014 (Bridge and Ketner, 1989) or the chicken adenovirus
CELO (chicken embryo lethal orphan) (Cotten et al., 1993b).
An advantage of the chicken adenovirus would be its inex-
pensive production and its safety since it is completely non-
infectious in humans. In addition, CELO virus displayed far
less cellular toxicity, allowing stable tansfection (Cotten et al.,
1993b). Figure 4 demonstrates the effect of adenovirus particles
on Tn-mediated gene delivery. As expected, human adenovirus
strongly augmented DNA transfection (Figure 4, no. 4; note
that all adenovirus experiments were carried out with 5 pg
lE3pL and 6 /tg pCLuc, while the chloroquine experiment was
done with 15 ng lE3pL and 18 fig pCLuc). In addition, CELO
virus also improved the DNA transfection (Figure 4, no. 2) and
indeed compensated for the 3-fold lower amount of pCLuc
DNA when compared to the chloroquine experiment (Figure 4,
no. 6). To determine the specificity of the DNA transfer,
lE3pL was replaced by free pL. In the case of human adeno-
virus, significant transgene expression was observed in the
absence of lE3pL (Figure 4, no. 3), suggesting its potential
infectivity for human cells. In contrast, no CELO virus-
mediated gene transfer was observed (Figure 4, no. 1), demon-
strating the decreased binding capacity of human cells for the
chicken virus. The use of 2- to 3-fold increased amounts of
lE3pL and DNA, keeping the ratio of 5:6 constant but without
adenovirus, also improved transfection efficiency remarkably.
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Fig. 1. Flow cytometric assessment of TfR, CD43 and Tn antigen expression. K562 (A) and Jurkat (B, C, D) cells were stained for flow cytometry as
described in Materials and methods. Expression of TfR (mAb B3/25) was analysed on K562 cultivated in normal medium (left peak) or medium containing
50 iM desferrioxamine (A), and on Jurkat cells (B). Expression of Tn antigen (mAb 1E3) was analysed before (left peak) and after VCN treatment (C).
CD43 expression on Jurkat cells is demonstrated by use of the sialidase-sensitive mAb DF-Tl (D). Antibody binding is abolished by VCN pre-treatment
(left peak). The ordinate (number of cells) is linear, whereas the abscissa (cell fluorescence intensity) is a logarithmic scale. Mean fluorescence intensities
(MFI) are presented in Table I.
Table I. Cell surface densities of TfR, CD43 and Tn antigen
Antigen Synonym Pre-treatment of cells MFI
TfR
Leukosialin
GalNAcal-O-Ser/Thr
CD71
CD43
Tn antigen
_
Desferrioxamine
-
VCN
-
VCN
K562
9.537
16.580
n.d.
n.d.
n.d.
n.d.
Jurkat
4.546
n.d.
13.990
0.820
48.080
81.750
Table I summarizes the mean fluorescence intensities (MFI) of the flow
cytograms presented in Figure 1. The MFI of the negative control
(secondary antibody alone) was 0.524 (K562) and 0.209 (Jurkat),
respectively, n.d. = not determined.
In this experiment, considerable luciferase activity was obtained
even in the absence of chloroquine (Figure 4, no. 5), suggesting
that the lysosomal degradation machinery or endosomal entrap-
ment was being saturated and that DNA started to reach the
nucleus under these conditions.
An extraordinary number of Jurkat cells express the
transfected gene
To assess the percentage of cells expressing the delivered gene,
we transfected the /3-galactosidase (lacZ) gene under the control
of the CMV promoter (MacGregor and Caskey, 1989) into
Jurkat cells by Tn-mediated endocytosis. In the cytochemical
staining presented in Figure 5, CELO virus samples resulted
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Light units
Fig. 2. Influence of the ratio of lE3pL conjugate to pCLuc DNA on
transfection efficiency. In a preliminary titration (nos 1-5), decreasing
amounts of lE3pL (from 13 to 5 /ig) were mixed with a constant amount
of pCLuc DNA (6 /tg) and transfected into Jurkat cells in the presence of
100 fM of chloroquine. For comparison, a previously determined optimal
ratio of TfpL and pCLuc DNA was delivered in the presence (no. 6) or
absence (no. 7) of chloroquine. The indicated luciferase light unit values
represent the averages of two transfections.
i o 2 i o 3 i o 4 t o 5 1 0 6 t o 7 i o
Fig. 4. Adenovirus particles augment DNA uptake. Human adenovirus (Ad)
H5rf/1014 or a chicken form of adenovirus (CELO) were used to augment
Tn-mediated gene delivery. pL was attached to virus particles by a
biotin-streptavidin linkage as described in Materials and methods.
Biotinylated virus particles were assembled into complexes containing
streptavidin-pL, DNA and, where indicated, 1E3 antibody-pL. To
determine the specificity of the virus-augmented DNA transfer, lE3pL was
replaced by free pL (nos 1 and 3). While 5 pt% of lE3pL and 6 iig of
pCLuc DNA were used for the virus-augmented DNA transfer (nos 2 and
4), 15 ng of lE3pL and 18 /ig of pCLuc DNA were also transfected in the
absence (no. 5) or presence (no. 6) of chloroquine. The indicated luciferase
light unit values are the averages of duplicate transfection experiments.
Light units
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Fig. 3. Specificity of the DNA transfer using lE3pL. Native (no. 1)
or VCN-pre-treated Jurkat cells (no. 2) were transfected with the
pre-determined optimal ratio of IE3pL and DNA in the presence of
chloroquine. As specificity controls, 50 ^ g (no. 3) or 100 /ig (no. 4)
of unconjugated 1E3 were added to the transfection medium (2.5 ml).
In addition, the transfection was carried out in the presence of free GalNAc
at 30 mM (no. 5). All transfections were set up in duplicate and mean
values of luciferase activity are presented.
in /3-galactosidase transgene expression in >60% of the cells.
When human adenovirus was used, 26% stained for /3-galacto-
sidase activity. The relatively weak support of H5rf/1014 is
most likely due to an increased cellular toxicity as compared to
CELO virus during a prolonged (48 h) expression time (Cotten
et al., 1993b). In experiments using chloroquine, 7% displayed
/3-galactosidase activity. In contrast, no blue cells were ob-
served when pCLuc was transfected, indicating that transgene-
encoded rather than endogenous galactosidase activity was
responsible for blue colour development. Generally, T-lym-
phoid cells proved to be relatively resistant to high-efficiency
transfection (Potter, 1988). With physical DNA transfer meth-
ods (as opposed to retroviral systems), transfection efficiencies
of - 1 % have been achieved so far (Bothwell, 1990). Thus, the
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Tn-mediated gene transfer to Jurkat cells described here dis-
plays a considerably high efficiency, representing a major
improvement of transfection efficiency over other physical
methods.
Discussion
The first structure of a cell that a DNA-loaded ligand en-
counters is the glycocalyx, a dense coat of sugars surrounding
each cell and serving various functions (Varki, 1993). It was,
therefore, tempting to target a carbohydrate structure in gene
transfer experiments. Cell surface carbohydrate antigens, and
in particular mucin-like O-linked carbohydrate clusters, present
several advantages as targets for the receptor-mediated gene
delivery. One established role of these O-linked carbohydrates
is that they confer a rod-like stem structure to the O-glyco-
sylated protein which therefore extends from the cell surface
(Carraway and Hull, 1991). At least physically, this protuber-
ant structure makes surface mucins potential targets for gene
delivery. Moreover, multiple O-linked carbohydrate side chains
may be attached to a single protein molecule of the mucin type
(Carraway and Hull, 1991). A major O-glycan-bearing glyco-
protein of T lymphoid cells is leukosialin (= CD43) (Anders-
son and Gahmberg, 1978; Brown et al., 1981). The number of
TfRs expressed on K562 cells which are targeted in the trans-
ferrinfection method has been estimated to be - 1 . 7 x 105/cell
(Mattia et al., 1984). Approximately 1.5 x IO5 CD43 mole-
cules are expressed per T cell (Barclay et al., 1993). However,
a single CD43 molecule may carry up to 80 Oglycosidic sugar
chains (Fukuda, 1991), resulting in 1.2 x IO7 CD43-asso-
ciated Tn antigens on Jurkat cells. In addition, Tn antigens on
Jurkat cells may also be attached to CD45, the leukocyte
common antigen, which contains a mucin-like domain (Barclay
et al., 1993), indicating that the total number of Tn epitopes per
Carbohydrate receptor-mediated gene transfer
1
Fig. 5. Cytochemical staining of Tn-transfected cells. The E.coli /3-galactosidase (lacZ) gene under the control of the CMV promoter was delivered to Jurkat
cells by Tn-mediated endocytosis. 0-Galactosidase activity was demonstrated in situ using X-gal as a chromogenic substrate. Gene transfer was augmented by
CELO virus (A), H5d/1014 (B) or chloroquine (C). As a control for endogenous /3-galactosidase activity, the pCLuc plasmid was delivered together with
H5rf/1014 (D). Magnification is X100 and 150-350 cells were counted for each experiment.
Jurkat cell is even higher. Furthermore, Tn may be expressed
on other Jurkat surface proteins which are not yet known to be
O-glycosylated. Indeed, for approximately half of all clustered
leukocyte antigens it is unknown whether they carry O-linked
oligosaccharides or not (Barclay et al., 1993). Taken together,
it seems obvious that the cell surface density of carbohydrate
receptors, in particular carbohydrate receptors of the mucin
type, is much higher when compared to protein receptors. This
calculation is also substantiated by the fluorescence intensities
presented in Table I which indicate a 10- to 18-fold excess of
Tn antigens over TfRs on Jurkat cells. It is reasonable to
assume that this high carbohydate receptor density is mainly
responsible for the efficient Tn-mediated gene delivery to Jurkat
T cells described in Figures 2 -5 . However, it should be men-
tioned that the affinity and avidity of anti-carbohydrate anti-
bodies is often lower as compared to anti-protein antibodies,
even though no correlation has been done in this case. In
addition, targeting mucin-type carbohydrate structures may not
be relevant for all cells since, for example, mucin proteins in
epithelial cells are preferentially secreted.
The carbohydrate receptor-mediated gene transfer described
here will provide a useful tool for both basic T-cell research and
for immunotherapy research which may require efficient trans-
fection of tumour-infiltrating T lymphocytes (Rosenberg et al.,
1990). This approach may also be useful for the generation of
genetically modified tumour cells as vaccines (Miller, 1992).
Targeting of the Tn antigen and its derivative the sialosyl-Tn
antigen, which are both expressed on many human primary
carcinoma cells (Itzkowitz et al., 1989; Springer, 1989), would
allow the specific gene transfer to tumour cells, but not to
normal cells also present in patient isolates. It is shown here that
the gene transfer mediated by mucin-type carbohydrates may
indeed be very efficient.
Materials and methods
Antibodies
mAb 1E3 was elicited using asialo ovine submaxillary mucin (asialo OSM) as
immunogen which contains the Tn antigen as the major carbohydrate component
(Schachter and Brockhausen, 1989). The hybridoma IE3 secreting Ig2a was
established using the NS-1 mouse myeloma fusion partner. IE3 was readily
inhibited by GalNAca-p-nitrophenyl. but not by the /3-anomeric configuration.
In addition, we have previously shown that 1E3 selectively binds to Tn
syndrome and Jurkat T cells (Thurnher et al.. 1992). both of which express the
Tn antigen, but not to normal donor T cells which lack detectable Tn antigen.
These data indicate that 1E3 indeed recognizes the Tn antigen. The anti-TfR
mAb B3/25 was obtained from Boehringer. DF-T1. the sialic acid (NeuAc)-
dependent (= sialidase-sensitive) ami-CD43 mAb was purchased from Dako.
Binding of mAb was revealed by fluoresceinated goat anti-mouse Ig (Southern
Biotechnology Assoc.).
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Syntheses of conjugates
Human TfpL with an average chain length of 300 lysines were prepared as
described previously (Wagner et al., 1991a). mAb 1E3 was obtained from
ascites after protein A purification and pL conjugates were prepared by
conjugation through disulphide bridges after modification with A'-succinimidyl
3-[2-pyridyldithio]propionate (SPDP) in analogous fashion as described pre-
viously (Wagner et al., 1990). Conjugates were obtained containing 1E3 and pL
(with an average chain length of 300 monomers) at a molar ratio of 1:2.
Biotinylated adenoviruses (H5d/1014 or CELO) and streptavidin-pL conjugates
were prepared as described previously (Wagner et al., 1992).
Cell culture and transfeclion
The culture medium RPMI 1640 (Gibco) was supplemented with 2 mM
L-glutamine, 100 U/ml penicillin, 100^g/ml streptomycin and 10% (v/v) heat-
inactivated fetal calf serum (FCS) (Gibco). Jurkat cells were maintained at
densities of 0.1-1 x 106 cells/ml. To ensure log-phase growth, cells were
diluted the day before transfection. Transfections were performed in 24-well
plates (2 ml/well) with 0.5 x 106 K562 cells or 1 x 106 Jurkat cells. To en-
hance TfR expression, K562 cells were pre-treated with 50 /xM desferrioxamine
for 18-24 h before transfection. When chloroquine was used, it was added just
before the transfection to a final concentration of 100 fiM. The plasmid pCLuc
carrying the firefly luciferase gene is described by Plank et al. (1992), and the
plasmid encoding the Escherichia coli /3-galactosidase gene is described by
MacGregor and Caskey (1989). DNA-lE3pL complexes were allowed to
form in 500 /tl of 150 mM NaCl and 20 mM HEPES (pH 7.4) (= HBS) within
30 min at room temperature and subsequently added to the cells. After a 4 h
incubation at 37°C, chloroquine-containing medium was replaced by fresh
culture medium and after an additional incubation for 24 (48) h, cells were
harvested for luciferase (/3-galactosidase) assay.
Human adenovirus H5rf/1014 (Bridge and Ketner, 1989) was grown on
W162 cells (Weinberg and Ketner, 1983) and purified by equilibrium banding
in CsCl and biotinylated as described previously (Cotten et al., 1993b). Com-
plexes were allowed to assemble as described previously (Wagner et al., 1992).
Briefly, biotinylated adenoviruses (H5<#1014 or CELO, 1010 viral particles)
were incubated with streptavidin-pL in 150 fil of HBS for 30 min at room
temperature. Addition of excess pCLuc DNA in 150 /tl of HBS resulted in
incomplete condensation of the DNA. After another 30 min at room tem-
perature, lE3pL was added in 100 fi\ of HBS, causing full condensation of
the DNA. After a further 30 min, the complexes consisting of virus, DNA and
1E3 antibody were added to the cells. After a 2 h incubation at 37°C, the
transfection medium was replaced by fresh culture medium and after 24-48 h,
as indicated, cells were again harvested for luciferase assay.
Reporter gene assays
Luciferase assay was carried out after 18-24 h of transgene expression
according to Brasier and Ron (1992), and luciferase activity was determined in
a luminometer (Berthold). The cytochemical staining for /3-galactosidase using
5-bromo-4-chloro-3-indolyl-/3-D-galactopyranoside (X-gal) as a chromogenic
substrate was performed after 48 h of expression according to Sanes et al.
(1986) and cells were inspected using an Olympus IM inverted microscope
equipped with an Olympus OM4 camera. Photographs were taken on Ekta-
chrome 64T.
Sialidase treatment and flow cytometry
Samples of 107 Jurkat cells were desialylated with 20 mU VCN (Boehringer)
in 1 ml phosphate-buffered saline (PBS) containing 0.5% (w/v) bovine serum
albumin (BSA) for 1 h at 37°C. The cells were then washed twice with PBS
containing 1 % (v/v) FCS.
Cells were stained at 5 x 105 cells/100 1^ sample for 30 min at 4°C. Cells
were first stained with culture supernatant containing 1E3 (10 fig/ml) or with
purified anti-TfR mAb (10 jtg/ml) according to the manufacturer's instructions,
followed by fluoresceinated goat anti-mouse Ig (50 /ig/ml) in PBS containing
10% FCS. After each incubation, cells were washed twice with PBS containing
1% FCS. After the final wash, cells were fixed in 2% (v/v) formaldehyde in
PBS containing 0.1 % FCS (the fixative was filtered prior to use) and kept at
4°C in the dark until analysis. Cells were analysed for immunofluorescence on
an EPICS Profile I flow cytometer. Data were presented with 'Elite' software
from Coulter.
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